SHZ · 002326.SZ
Zhejiang Yongtai Technology Co.,Ltd.
CN¥14.33+CN¥0.11 (+0.77%)
Zhejiang Yongtai Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.58% below the high.
Loading market information…
SHZ · 300497.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangxi Fushine Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangxi Fushine Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 1.45% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jiangxi Fushine Pharmaceutical Co., Ltd.’s next earnings report is currently expected on May 3, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangxi Fushine Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jiangxi Fushine Pharmaceutical Co., Ltd. is engaged in the global research, development, production, and marketing of active pharmaceutical ingredients (APIs) and key chemical compounds for drug synthesis. Its product portfolio includes important antibiotics like penicillin and carbapenem, alongside a variety of other pharmaceutical offerings. The company also extends its expertise by providing contract research, development, and manufacturing services. Founded in 2002 and headquartered in Jingdezhen, China, the firm was initially named Jingdezhen Fuxiang Pharmaceutical Co., Ltd. before adopting its current designation in August 2012.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Apr 25, 2025 | -CN¥0.36 | CN¥200.97M-55.24% vs estimate |
|---|
| Q1 2025 | Apr 25, 2025 | CN¥0.00-97.22% vs estimate | CN¥233.70M-47.95% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥14.33+CN¥0.11 (+0.77%)
Zhejiang Yongtai Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.58% below the high.
CN¥6.86+CN¥0.12 (+1.78%)
Shandong Lukang Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.01% below the high.
CN¥20.24+CN¥0.19 (+0.95%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.19% below the high.
CN¥7.39+CN¥0.18 (+2.5%)
Zhejiang Ausun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.64% below the high.
CN¥6.91+CN¥0.13 (+1.92%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.95% below the high.
CN¥4.83+CN¥0.06 (+1.26%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.77% below the high.
CN¥12.95+CN¥0.16 (+1.25%)
Jiangsu Lianhuan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.87% below the high.
CN¥15.27-CN¥0.19 (-1.23%)
Hefei Lifeon Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.47% below the high.
